Invesco India Large & Mid Cap Fund
Institution · data to Mar 2026
Disclosed value
₹1,238 Cr
Mar 2026 closes
At current prices
…
Current holdings
2
Tracked since
Sep 2024
Portfolio value over time
Sum of disclosed holdings across all combined entities, valued at each quarter's closing price.
Current holdings (Mar 2026)
| Company | Holding | QoQ | Value |
|---|---|---|---|
| Glenmark Pharmaceuticals Ltd | 1.88% | 0.50 | ₹1,112 Cr |
| Sobha Ltd | 1.02% | NEW | ₹126 Cr |
Portfolio Summary
Mar 2026As of Mar 2026, Invesco India Large & Mid Cap Fund — an institution tracked through public shareholding filings — disclosed 2 holdings in Indian listed companies worth ₹1,238 crore. The same holdings-at-filing-value basis put it at ₹1,384 crore in Dec 2025 (−10.6%). Solomo carries these filings back to Sep 2024.
Largest disclosed positions in Mar 2026: Glenmark Pharmaceuticals Ltd (GLENMARK — 1.88% of the company, ₹1,112 crore); Sobha Ltd (SOBHA — 1.02% of the company, ₹126 crore).
Changes in the Mar 2026 filings: newly disclosed — Sobha Ltd. Stake reduced in Glenmark Pharmaceuticals Ltd (−0.50 pp).
| Quarter | Disclosed value | Change |
|---|---|---|
| Mar 2026 | ₹1,237 Cr | −10.6% |
| Dec 2025 | ₹1,384 Cr | +193.3% |
| Sep 2025 | ₹472 Cr | +150.8% |
| Jun 2025 | ₹188 Cr | - |
| Sep 2024 | ₹199 Cr | - |